Insulin amyloid at injection sites of patients with diabetes
- 9 May 2016
- journal article
- case report
- Published by Taylor & Francis Ltd in Amyloid
- Vol. 23 (3), 139-147
- https://doi.org/10.1080/13506129.2016.1179183
Abstract
The formation of insulin amyloid can dramatically impact glycemic control in patients with diabetes, making it an important therapeutic consideration. In addition, the cost associated with the excess insulin required by patients with amyloid is estimated to be $3K per patient per year, which adds to the growing financial burden of this disease. Insulin amyloid has been observed with every mode of therapeutic insulin administration (infusion, injection and inhalation), and the number of reported cases has increased significantly since 2002. The new cases represent a much broader demographic, and include many patients who have used exclusively human insulin and human insulin analogs. The reason for the increase in case reports is unknown, but this review explores the possibility that changes in patient care, improved differential diagnosis and/or changes in insulin type and insulin delivery systems may be important factors. The goal of this review is to raise key questions that will inspire proactive measures to prevent, identify and treat insulin amyloid. Furthermore, this comprehensive examination of insulin amyloid can provide insight into important considerations for other injectable drugs that are prone to form amyloid deposits.Keywords
This publication has 76 references indexed in Scilit:
- Functional Amyloids Composed of Phenol Soluble Modulins Stabilize Staphylococcus aureus BiofilmsPLoS Pathogens, 2012
- Disulfide Bridges Remain Intact while Native Insulin Converts into Amyloid FibrilsPLOS ONE, 2012
- Complications of continuous intraperitoneal insulin infusion with an implantable pumpWorld Journal of Diabetes, 2012
- Executive Summary: Standards of Medical Care in Diabetes—2012Diabetes Care, 2011
- Short-Term Exenatide Treatment Leads to Significant Weight Loss in a Subset of Obese Women Without DiabetesDiabetes Care, 2011
- Nodular amyloidosis in a diabetic patient with frequent hypoglycemia: Sequelae of repeatedly injecting insulin without site rotationJournal of the American Academy of Dermatology, 2010
- Localized cutaneous amyloid at an insulin injection siteClinical and Experimental Dermatology, 2009
- Molecular basis for insulin fibril assemblyProceedings of the National Academy of Sciences of the United States of America, 2009
- Amyloid as a Depot for the Formulation of Long-Acting DrugsPLoS Biology, 2008
- The Component Polypeptide Chains of Bovine Insulin Nucleate or Inhibit Aggregation of the Parent Protein in a Conformation-dependent MannerJournal of Molecular Biology, 2006